Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2020-01-30 | 2020-07-09 | 104922 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120905 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-06-19 | 2023-08-17 | 195629 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2025-01-30 | 2025-01-30 | 249182 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-04-10 | 2023-10-03 | 111874 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2024-10-11 | 2025-09-02 | 240028 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-02-09 | 2023-07-05 | 184195 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2024-10-11 | 2025-09-02 | 240037 |
| AERMONY RESPICLICK | 232MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-04-28 | 176860 |
| AERMONY RESPICLICK | 55MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-01-18 | 176791 |
| ALERTEC | 100MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167165 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2020-11-06 | 2021-03-18 | 128031 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2021-07-08 | 2021-08-24 | 142189 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 250MG | POWDER FOR SOLUTION | Resolved | 2021-10-28 | 2021-11-25 | 148421 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-06-03 | 2021-08-05 | 140369 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1000MG | POWDER FOR SOLUTION | Resolved | 2019-06-18 | 2019-09-19 | 86939 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 250MG | POWDER FOR SOLUTION | Resolved | 2025-04-04 | 2025-10-10 | 254136 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Actual shortage | 2025-06-19 | 2025-12-18 | 260642 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2025-06-05 | 2025-12-11 | 259685 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2021-08-13 | 2021-10-07 | 144105 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |